Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J3240 Thyrotropin injection

J Codes (Drugs)

Also known as: thyrotropin, TSH, Thyrogen

Thyrotropin (TSH) injection is a recombinant thyroid-stimulating hormone used to enhance radioiodine uptake in thyroid cancer patients and for thyroid imaging.

In Plain Language

thyroid stimulation injection; thyroid cancer imaging aid

Clinical Context

Used in thyroid cancer patients to enhance radioiodine uptake for diagnostic imaging and therapeutic ablation. Administered intramuscularly before radioiodine therapy. Allows radioiodine treatment without thyroid hormone withdrawal.

RVU Information

CPT J3240 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

EndocrinologyOncologyNuclear Medicine

Frequently Asked Questions

What is CPT code J3240?

CPT J3240 (Thyrotropin injection) is a J Codes (Drugs) code. Thyrotropin (TSH) injection is a recombinant thyroid-stimulating hormone used to enhance radioiodine uptake in thyroid cancer patients and for thyroid imaging.

How is J3240 administered?

CPT J3240 is administered by a healthcare provider, typically via injection or infusion. Used in thyroid cancer patients to enhance radioiodine uptake for diagnostic imaging and therapeutic ablation. Administered intramuscularly before radioiodine therapy. Allows radioiodine treatment without thyroid hormone withdrawal. It is used by Endocrinology, Oncology, Nuclear Medicine.

When is CPT J3240 used?

Used in thyroid cancer patients to enhance radioiodine uptake for diagnostic imaging and therapeutic ablation. Administered intramuscularly before radioiodine therapy. Allows radioiodine treatment without thyroid hormone withdrawal.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.